Major Investment in AI-Driven Precision Medicine at the University of Skövde featuring RealSeq Biosciences
The University of Skövde is launching a major initiative in the biomedical field. In collaboration with the Knowledge Foundation and 13 partner companies, the University is starting an eight-year research and education initiative focused on AI-driven development of precision medicine.
Four Focus Areas
The initiative in AI-driven precision medicine at the University of Skövde is named AID-PM (Artificial Intelligence-Driven Precision Medicine). The initiative spans eight years and totals SEK 92 million, of which the Knowledge Foundation contributes SEK 48 million. A total of 13 partner companies are involved: AstraZeneca, VERIGRAFT, Takara Bio Europe, RISE Research Institutes of Sweden, RealSeq Biosciences, Kontigo Care, 1928 Diagnostics, QIAGEN, MULTID ANALYSES AB, SciCross, Unilabs, CCRM Nordic and Skillsta teknik och design.
